Call Today: (800) 889-3898
Contact us for free information or to start a free case review.
After months of investigation, the U.S. Food and Drug Administration has definitively tied three patient deaths to contaminated heparin.
Heparin is a widely used blood thinning medication, primarily administered to dialysis and cardiac surgery patients. Earlier this year, the leading supplier of heparin in the U.S. , Baxter International Inc., issued a recall over possible contamination after a spike in the number of allergic reactions.
Ninety-three deaths were reported in association with heparin use between January and the end of March, and ten of those involved death from anaphylaxis, a severe allergic reaction. The FDA concluded that three of those ten patients received heparin from contaminated batches.
“We have what looks like a cause and effect in some patients. We know that they got contaminated heparin, and they died subsequently. This is one of the final links in the chain,” said Dr. Janet Woodcock of the FDA.
Lot numbers were not available for the heparin administered to the other seven patients.
Additionally, thirteen of the remaining 83 deaths were likely due to “potential complications of heparin use,” and 25 were due to unrelated causes. For the remaining 45 deaths, the FDA said not enough clinical information was provided to determine whether contaminated heparin was to blame.
(Source: Chicago Tribune)
Injured by contaminated heparin? Contact us today to talk to an experienced heparin attorney about your circumstances.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.